On Dec. 18, Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) announced that the application of European patent number 2,222,278 was allowed by the European Patent Office. The new patent, “Improved Taxane Delivery System,” covers the Company’s proprietary taxane prodrug nanoparticle delivery technology and CPX-8, a hydrophobic docetaxel prodrug nanoparticle, which is based on this innovative approach to drug delivery. Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) belongs to Healthcare sector. Its … Continue reading Morning Movers: Celator Pharmaceuticals, Inc. (NASDAQ:CPXX), Atmel Corporation (NASDAQ:ATML), Home Loan Servicing Solutions, Ltd. (NASDAQ:HLSS), ON Semiconductor Corp. (NASDAQ:ONNN), Can-Fite BioPharma (NYSEMKT:CANF)